CureCode

CureCode is a South Korean biotechnology company specializing in microbiome-based skin science and the development of advanced dermatological treatments. The company's core innovation is Neuromide, a proprietary microbiome-derived metabolite that targets cannabinoid receptors in the skin to enhance barrier function and reduce inflammation. CureCode focuses on addressing chronic skin conditions such as atopic dermatitis and hypersensitivity through a combination of pharmaceutical research and high-end cosmeceuticals. By leveraging its microbiome insights, the company aims to provide long-term solutions for skin health. Their platform integrates bioinformatics and clinical dermatology to identify novel bioactive compounds produced by beneficial skin bacteria.